A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
| Image |  |
|---|---|
| Description | scientific article published on 31 October 2019 |
| Author/s |
author: Stacey Chuma Romanos Sklavenitis-Pistofidis Kaitlen Reyes Jacob P Laubach Irene Ghobrial Kalvis Hornburg Rachid Baz Pamela S Becker Paul G. Richardson Kenneth C. Anderson |
| Publication date | October 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |